Breaking News
Investing Pro 0
Close

Unity Biotechnology Inc (UBX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Unity Biotech's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.930 +0.130    +2.71%
11:18:22 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 109,959
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 4.800 - 5.118
Unity Biotech 4.930 +0.130 +2.71%

UBX Financial Summary

 
A brief financial summary of Unity Biotechnology Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Unity Biotechnology, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 13.71 million compared to USD 16.45 million a year ago. Basic loss per share from continuing operations was USD 1.36 compared to USD 2.97 a year ago.For the nine months, net loss was USD 45.76 million compared to USD 50.03 million a year ago. Basic loss per share from continuing operations was USD 5.77 compared to USD 9.13 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

UBX Income Statement

Gross margin TTM -625.1%
Operating margin TTM -1,028.94%
Net Profit margin TTM -1,124.52%
Return on Investment TTM -35.84%
 Total Revenue  Net Income
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Revenue 0.236 0 4.78
Gross Profit -8.21 0.236 -11.26
Operating Income -13.13 -12.26 -16.67
Net Income -13.71 -13.14 -18.92

UBX Balance Sheet

Quick Ratio MRQ 5.9
Current Ratio MRQ 6.12
LT Debt to Equity MRQ 16.88%
Total Debt to Equity MRQ 64.72%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Assets 136.39 97.59 112.47 124.71
Total Liabilities 57.83 57.66 61.78 65.14
Total Equity 78.56 39.93 50.69 59.57

UBX Cash Flow Statement

Cash Flow/Share TTM -3.26
Revenue/Share TTM 0.36
Operating Cash Flow  -64.76%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -10.86 -14.84 -14.97
Cash From Investing Activities -36.23 17.69 -5.82
Cash From Financing Activities 50.22 0.138 4.33
Net Change in Cash 3.13 3 -16.46
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

UBX Comments

Write your thoughts about Unity Biotechnology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Eren Eren
Eren Eren Jan 28, 2022 9:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I will buy this for my grandchildren!
JOHN ADAM
JOHN ADAM Jan 28, 2022 9:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
100 DOLARLIK al bekle 3 gune satarsin!
mochamad Khasan
mochamad Khasan Jan 28, 2022 9:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you think is good this stock and also good make money,please let me know if this good for the future and maybe i will buy too thanks
Yuliya Tenbruinskyy
Yuliya Tenbruinskyy Jan 18, 2021 8:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If bezos and thiel are in, im in
NY Brokers Stock Exchange
NY Brokers Stock Exchange Jan 18, 2021 8:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now my sweet Yuliya what please ? pozalusta ? to entry inside you or not to entry ? best regars., Panagiotakis to kalo paidi.!
NY Brokers Stock Exchange
NY Brokers Stock Exchange Jan 18, 2021 8:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
to entry in Unity or not to entry what do you think ? best regards., Panagiotakis.
Shlomi Berg
Shlomi Berg Sep 15, 2020 2:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
15% up?
Yin LeGrand
Yin LeGrand Sep 04, 2020 10:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I would be too beautiful if their drug candidates worked. Unfortunately, the data says otherwise. They still have a few in the pipeline, and some cash to burn. Eventually they will have to issue more shares or issue large debts (Powell to buy?).. So, expect 1-5$ range for a while.
Luis Niev
Luis Niev Aug 21, 2020 3:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bad stock no future.😢😢
luis Nieves
luis Nieves Aug 18, 2020 2:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
never...
Gilles Nadon
Gilles Nadon Aug 17, 2020 5:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will this go back up
luis Nieves
luis Nieves Aug 17, 2020 11:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bear very fear
Farry Hardianto
Farry Hardianto Aug 17, 2020 8:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.globenewswire.com/news-release/2020/08/17/2079116/0/en/UNITY-Biotechnology-Announces-12-week-data-from-UBX0101-Phase-2-Clinical-Study-in-Patients-with-Painful-Osteoarthritis-of-the-Knee.html
MoneyManager MoneyManager
Money2Manage4U Aug 15, 2020 2:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it true that Jeff Bezos from Amanon  invested 300mln USD in this company ?
tom abc
investingA Aug 15, 2020 2:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i think that he deed
Ralph Lynch
Ralph Lynch Aug 15, 2020 2:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tom abc https://www.cnbc.com/2018/08/29/jeff-bezos-backs-silicon-valley-scientist-working-on-a-cure-for-aging.html
MoneyManager MoneyManager
Money2Manage4U Aug 15, 2020 2:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ralph Lynch is it worth to entry for short or for mid - long term period ?
MoneyManager MoneyManager
Money2Manage4U Aug 15, 2020 2:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tom abc is it worth to entry in this equity for short or for mid long term please ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email